FR2528837B1 - - Google Patents

Info

Publication number
FR2528837B1
FR2528837B1 FR8210630A FR8210630A FR2528837B1 FR 2528837 B1 FR2528837 B1 FR 2528837B1 FR 8210630 A FR8210630 A FR 8210630A FR 8210630 A FR8210630 A FR 8210630A FR 2528837 B1 FR2528837 B1 FR 2528837B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8210630A
Other languages
French (fr)
Other versions
FR2528837A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THERAPEUTIQUE APPLIC SA
Original Assignee
THERAPEUTIQUE APPLIC SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THERAPEUTIQUE APPLIC SA filed Critical THERAPEUTIQUE APPLIC SA
Priority to FR8210630A priority Critical patent/FR2528837A1/fr
Priority to CH320483A priority patent/CH657125B/fr
Priority to NL8302087A priority patent/NL8302087A/nl
Priority to GR71641A priority patent/GR78284B/el
Priority to DE3321772A priority patent/DE3321772A1/de
Priority to GB08316516A priority patent/GB2122195A/en
Priority to KR1019830002710A priority patent/KR860001339B1/ko
Priority to JP58108026A priority patent/JPS5910571A/ja
Priority to BE0/211031A priority patent/BE897085A/fr
Priority to IT8321684A priority patent/IT1194281B/it
Publication of FR2528837A1 publication Critical patent/FR2528837A1/fr
Application granted granted Critical
Publication of FR2528837B1 publication Critical patent/FR2528837B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8210630A 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication Granted FR2528837A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR8210630A FR2528837A1 (fr) 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication
CH320483A CH657125B (ru) 1982-06-18 1983-06-10
NL8302087A NL8302087A (nl) 1982-06-18 1983-06-11 Pyridazinonverbindingen, werkwijze voor de bereiding hiervan en de toepassing als geneesmiddel.
GR71641A GR78284B (ru) 1982-06-18 1983-06-13
DE3321772A DE3321772A1 (de) 1982-06-18 1983-06-16 Pyridazinon-derivate, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
GB08316516A GB2122195A (en) 1982-06-18 1983-06-17 Pyridazinones
KR1019830002710A KR860001339B1 (ko) 1982-06-18 1983-06-17 피리다지논 유도체의 제조방법
JP58108026A JPS5910571A (ja) 1982-06-18 1983-06-17 医薬品として使用可能なピリダジノンの誘導体、及びそれの製造方法
BE0/211031A BE897085A (fr) 1982-06-18 1983-06-17 Derives de pyridazinones utilisables comme medicaments et procedes pour leur fabrication
IT8321684A IT1194281B (it) 1982-06-18 1983-06-17 Derivati di piridazinoni impiegabili come sostanze medicinali e procedimento per la loro fabricazione

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8210630A FR2528837A1 (fr) 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication

Publications (2)

Publication Number Publication Date
FR2528837A1 FR2528837A1 (fr) 1983-12-23
FR2528837B1 true FR2528837B1 (ru) 1984-12-07

Family

ID=9275129

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8210630A Granted FR2528837A1 (fr) 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication

Country Status (10)

Country Link
JP (1) JPS5910571A (ru)
KR (1) KR860001339B1 (ru)
BE (1) BE897085A (ru)
CH (1) CH657125B (ru)
DE (1) DE3321772A1 (ru)
FR (1) FR2528837A1 (ru)
GB (1) GB2122195A (ru)
GR (1) GR78284B (ru)
IT (1) IT1194281B (ru)
NL (1) NL8302087A (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666902A (en) * 1983-06-20 1987-05-19 Cassella Aktiengesellschaft Tetrahydropyridazinone derivatives, processes for their preparation and their use
EP0210530A1 (de) * 1985-07-27 1987-02-04 MERCK PATENT GmbH 6-Arylalkenylpyridazinone
JPS63220512A (ja) * 1987-03-09 1988-09-13 松下電器産業株式会社 電解コンデンサ用電極箔
JPH04100106U (ru) * 1991-02-12 1992-08-28
JPH0776050B2 (ja) * 1991-07-25 1995-08-16 実 近藤 ワークの移送装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2304977A1 (de) * 1973-02-01 1974-08-08 Basf Ag Neue dihydropyridazinone

Also Published As

Publication number Publication date
IT1194281B (it) 1988-09-14
FR2528837A1 (fr) 1983-12-23
JPS5910571A (ja) 1984-01-20
GR78284B (ru) 1984-09-26
IT8321684A0 (it) 1983-06-17
GB2122195A (en) 1984-01-11
CH657125B (ru) 1986-08-15
GB8316516D0 (en) 1983-07-20
KR860001339B1 (ko) 1986-09-15
NL8302087A (nl) 1984-01-16
BE897085A (fr) 1983-12-19
DE3321772A1 (de) 1983-12-22
KR840005105A (ko) 1984-11-03

Similar Documents

Publication Publication Date Title
FR2520616B1 (ru)
DE3348027A1 (ru)
FR2522614B1 (ru)
FR2522905B1 (ru)
FR2523345B1 (ru)
FR2520169B3 (ru)
FR2519336B1 (ru)
FR2520155B1 (ru)
DK344084D0 (ru)
DE3378479T2 (ru)
FR2520570B1 (ru)
FR2523060B3 (ru)
FR2521987B1 (ru)
FR2519761B1 (ru)
FR2523840B3 (ru)
FR2523293B1 (ru)
FR2519812B2 (ru)
FR2528837B1 (ru)
CH655639B (ru)
FR2522586B1 (ru)
FR2523446B3 (ru)
FR2521692B1 (ru)
FR2522731B1 (ru)
FR2523925B3 (ru)
FR2520944B1 (ru)

Legal Events

Date Code Title Description
ST Notification of lapse